Tax Credits

I read the article "A Plan For Revitalizing Science And Technology: Grants With Tax Credits" by Dudley G. Moon and John W. Fenton II in the Opinion section of the Jan. 8, 1996, issue of The Scientist [page 10]. I would like to express my full support for the ideas set forth by these scientists. I think it is about time we took such measures to boost extra resources for the future of biomedical research in the United States. The current amount of government funds will not be enough to support

Written byAlireza Rezaie
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I read the article "A Plan For Revitalizing Science And Technology: Grants With Tax Credits" by Dudley G. Moon and John W. Fenton II in the Opinion section of the Jan. 8, 1996, issue of The Scientist [page 10]. I would like to express my full support for the ideas set forth by these scientists.

I think it is about time we took such measures to boost extra resources for the future of biomedical research in the United States. The current amount of government funds will not be enough to support much-needed progress in basic science in the future. As these scientists proposed, we need to have other funding agencies, and what better than grants with tax credits?

This system of funding, as explained nicely in the article, is beneficial for everybody: for the industries, for the public, and finally for the scientists, who can spend their valuable time on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies